Driving Excellence in Active Pharmaceutical Ingredients since 1963
High-quality APIs with value added services
Best value based on better access, better quality, and better supply of APIs
As part of TIEFENBACHER GROUP, a 100% family-owned leading health care company, TIEFENBACHER API provides a full and complementary range of high-quality raw materials and value-added services throughout the entire life cycle of pharmaceutical products. Established as the world’s first exclusive API distributor in 1963, we are a pioneer in the supply of the European pharmaceutical industries with the finest APIs of distinguished manufacturers around the globe. Today we distribute our portfolio of 600+ APIs to more than 250 customers in more than 30 European countries.
Thereby we are daily driven by our commitment that every API shipment is delivering on our best value seal: offering our customers a BETTER ACCESS, a BETTER QUALITY, and a BETTER SUPPLY of APIs.

Tiefenbacher API + Ingredients: local knowledge with worldwide expertise
This makes us successful since 1963
600+
APIs
250+
European customers
100+
audits
130+
manufacturers
600+
APIs
250+
European customers
100+
audits
130+
manufacturers
own qualified warehouse
market intelligence
supplier qualification
quality assurance (QA)
own warehouse
market intelligence
supplier qualification
quality assurance (QA)
Best Value based on better access, better quality, and better supply
Our Business Model – Quality comes first
TIEFENBACHER API sources and supplies high-quality APIs with a extended range of value added services. Hereby we are commited to provide products of the highest quality that meet customers needs as well regulatory requirements.

Best Value based on better access, better quality, and better supply
Our Business Model – Quality comes first
TIEFENBACHER API sources and supplies high-quality APIs with a extended range of value added services. Hereby we are commited to provide products of the highest quality that meet customers needs as well regulatory requirements.

How we cooperate with our supply partners
Benefits for our Supply Partners | Manufacturers:
TIEFENBACHER API: your market-leading Partner for Europe
Maximize sales in a safe and a simple way with us
Our excellent sector expertise, efficient presence on the European market as well as our long-lasting infrastructure form the basis for our supply partners to expand your European business activities sustainably, safely and profitably. Our range of services covers the whole value chain, including market entry advice/analysis, quality assurance/regulatory affairs, marketing/sales as well as logistics.
Tiefenbacher API as part of the Tiefenbacher Group
creating value for patients by bringing Innovations to life
Our Vision
Improving the life of millions of patients
worldwide by making a difference
in tomorrow´s health.
Our Mission
Creating high-quality pharmaceuticals for
the most trusted brands - more affordable,
more available, and better than before.
Tiefenbacher group company values:
The courage to shape a better future
Always one step ahead – this is how we work, this is how we think
Our history: Pioneering Healthcare since 1963
Over 55 years track record of industry firsts
Founded in 1963 as the world’s first exclusive agency for active pharmaceuticals ingredients (API), TIEFENBACHER has been grown into a leading health care company providing innovative and best-in-class solutions along the entire pharmaceutical value chain. Representing API producers has provided the foundation for TIEFENBACHER´s growth into a fully fledged pharmaceutical company – capable of developing, registering, and supplying finished dosage form (FDF) pharmaceuticals to marketing organizations worldwide. In over 55 years of our company history we have shown an outstanding track record in anticipating new developments as well as launching new businesses.
At a glance: TIEFENBACHER GROUP milestones

- 1963
- 1964
- 1974
- 1995
- 2000
- 2002
- 2003
- 2009
- 2013
- 2016
- 2018
- 2019
- 2019
- 2020
Foundation by Alfred E. Tiefenbacher in Hamburg
Foundation by Alfred E. Tiefenbacher in Hamburg
3rd Employee
3rd Employee
Move to new address in villa on Harvestehuder Weg
Move to new address in villa on Harvestehuder Weg
First generic drug development of finished dosage form (FDF)
First generic drug development of finished dosage form (FDF)
First EU marketing authorization under own name
First EU marketing authorization under own name
Move to new headquarters at port of Hamburg
Move to new headquarters at port of Hamburg
Opening of AET Labs (India)
Opening of AET Labs (India)
Acquisition of Delorbis Pharmaceuticals manufacturing site (Cyprus)
Acquisition of Delorbis Pharmaceuticals manufacturing site (Cyprus)
Celebration of the 50th anniversary of Tiefenbacher Group
Celebration of the 50th anniversary of Tiefenbacher Group
Foundation of AET Medical Products
Foundation of AET Medical Products
First NCE submission under own name
First NCE submission under own name
FDA approval of AET Labs manufacturing site
FDA approval of AET Labs manufacturing site
First FDF US submission under own name
First FDF US submission under own name
First medical device CE certification
First medical device CE certification
Our founder Alfred E. Tiefenbacher
Pioneer of the pharmaceutical industry
Our entrepreneurial spirit is firmly anchored in our founder and owner family since 1963.
The foundation for this success story was the pioneer spirit of the company´s founder and namesake Alfred E. Tiefenbacher (+1993). Until today his unique entrepreneur mind is one important pillar of TIEFENBACHER´s corporate culture: our about 600 employees are always challenging the status quo and striving for new patient orientated solutions – in terms of business models as well as concrete products and services for our customers and partners.

TIEFENBACHER API Management
our managing directors
TIEFENACHER API, as a part of the TIEFENBACHER GROUP, is led by a seasoned team of executives. Their cumulative knowledge and combined professional backgrounds add up to unparalleled leadership that keeps our company always a step ahead of the industry and in sync with our customers ‘ needs.
Sören Schlosser
Sören has held various leading positions at international distribution companies. Besides global sales and purchase as well as marketing and quality assessments he was responsible for a Post-Merger Integration process of an internationally operating distribution company. Sören joined TIEFENBACHER API in 2018 and is responsible for sales, assortment, and supply chain management.
Sören is married and a father of two.
Oliver Schrader
Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined TIEFENBACHER API in 2016 and is responsible for business development and quality management.
Oliver is married and a father of three.

Sören Schlosser
Sören has held various leading positions at international distribution companies. Besides global sales and purchase as well as marketing and quality assessments he was responsible for a Post-Merger Integration process of an internationally operating distribution company. Sören joined TIEFENBACHER API in 2018 and is responsible for sales, assortment, and supply chain management.
Sören is married and a father of two.

Oliver Schrader
Oliver spent the vast majority of his global career in the branded consumer goods industry. Besides leading functions in marketing and sales he served as managing director of German Dax and skin care company Beiersdorf in Ukraine, South Africa and North America. Oliver joined TIEFENBACHER API in 2016 and is responsible for business development and quality management.
Oliver is married and a father of three.
TIEFENBACHER GROUP –
present in over 80 countries
Our path to profitable growth

Tiefenbacher Group
Webcam Hamburg
Contact –
Partner with us
As the builders of the future, we are working to improve people´s lives.
By thinking beyond healthcare.

TIEFENBACHER API + INGREDIENTS GMBH & CO. KG
Van-der-Smissen-Strasse 1-2
22767 Hamburg
Germany
Phone: +49 40 – 36 09 18 – 0
Fax: +49 40 – 36 09 18 – 222
Mail: info@tifi-api.eu
Pioneership
Achiever by curiosity
- We are always challenging the status quo and striving for new patient orientated solutions – in terms of business models as well as concrete products and services for our customers and partners.
- We believe that the basis for our innovation power is curiosity – the curiosity of each of our employees dedicated to make patients´ life better.
- This entrepreneurial spirit is firmly anchored in our founder and owner family since 1963 – making us a health pioneer.
Excellence
Know-how by Enthusiasts
- Our experience of almost 60 years in the pharmaceutical industry and the constant development of our group allow us to deliver premium value to our customers and partners along the whole pharmaceutical supply chain.
- The world most trusted brands count on our high excellence in research and development and reliable quality assurance building the foundation for our broad and innovative product portfolio.
- Our strong track record in gaining international marketing authorizations in 80+ countries leads to a global availability of our high-quality developments.
- We drive efficiency by keeping our supply chains simple and reaching economies of scales in our own manufacturing sites resulting in best value for money for our customers.
- About 600 highly skilled employees worldwide and a unique global network of partners are the key for our high level of excellence.
Patient Focus
Value by Innovations
- All our activities are focused on making patients´ lives better by creating pharmaceuticals more available, more affordable, and better than before.
- We believe that high-quality medicine should be affordable and available to everyone – irrespective of their income, their origin or their nationality.
- We also believe that there are always new ways of smart medicines which better deliver on patients´ needs.
- To better understand patients´ needs we are in close and regularly collaboration with universities and key opinion leaders of all relevant disciplines.